Tezcat

Principal Investigators: Dafna Bar-Sagi, PhD/Shohei Koide, PhD

Tezcat Biosciences is developing a RAS Therapeutic Discovery Platform to unlock the full potential of druggable targets. Tezcat combines validated discovery tools and their proprietary enabling technology to create new therapies. The Discovery Platform is scalable, as it can be applied to context-dependent iterations and various indications to support both internal R&D and strategic partnerships.